Patient-reported disability has insufficient clinical accuracy for predicting physical function in survivors of critical illness: a secondary analysis of a cluster-randomised trial
In brief
Disability scores cannot reliably predict physical function after critical illness
In 620 ICU survivors assessed six months after discharge, higher disability scores tracked with weaker grip and shorter walking distance, but only moderately. Predictions were too imprecise to distinguish clinically meaningful differences, and 59% did not complete the 2-minute walk test. Remote disability questionnaires may help assess patients who cannot attend clinic, but cannot replace physical function testing.
- Journal
- British journal of anaesthesia (Q1)
- Published
- 10 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Nicolas Paul, Elena Ribet, Julius J Grunow, Andreas Edel, Claudia D Spies, Björn Weiss
- PMID
- 43009368
- DOI
- 10.1016/j.bja.2026.10.002
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (top studies of the week, 15 November 2026): Physical disability and functional outcomes after critical illness
Abstract
BACKGROUND: Post-ICU care often misses patients unable to attend in-person clinic visits. Remote assessments of physical function might increase access to ICU aftercare. We investigated whether patient-reported disability predicts handgrip strength (HGS) and the 2-Minute Walk Test (2MWT) distance with sufficient clinical accuracy. METHODS: This secondary analysis of the stepped-wedge cluster-randomised Enhanced Recovery after Intensive Care trial included patients from 10 German ICU clusters who completed the WHO Disability Assessment Schedule (WHODAS) 2.0 plus either HGS, the 2MWT, or both, 6 months after ICU discharge. Relationships between WHODAS 2.0, HGS, and 2MWT were analysed using scatter plots, correlation coefficients, linear regressions, and Bland-Altman plots. Predictions of HGS and the 2MWT were compared with the minimal clinically important difference (MCID) for both measures. RESULTS: Of 1463 enrolled patients, 620 were analysed. The median WHODAS 2.0 sum score was 11 (Q1, Q3: 3, 22). The median HGS, expressed as a percentage of the expected value (%exp), was 70.6%exp (Q1, Q3: 54.4, 85.6), and the median 2MWT distance was 73.7%exp (Q1, Q3: 61.5, 85.8). The 2MWT was not completed by 59% of patients. Higher disability was moderately correlated with lower HGS (Spearman %exp: -0.41) and shorter 2MWT distance (Spearman %exp: -0.47). In multivariable regression models, the WHODAS 2.0 sum score predicted HGS in kg (β: -0.27 [95% CI: -0.33 to -0.22]; P<0.001) and 2MWT distance in m (β: -1.94 [95% CI: -2.37 to -1.51]; P<0.001), but the limits of agreement exceeded the MCIDs. CONCLUSIONS: With increasing disability, HGS and 2MWT performance declined, although correlations were moderate and uncertainty of predictions exceeded MCIDs of both instruments. Remote WHODAS 2.0 assessments cannot replace in-person physical function testing. CLINICAL TRIAL REGISTRATION: NCT03671447.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.